MONIKA WALIA: Open Payments
NPI 1275288037 · HAYWARD, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$739 in 21 payments from 13 companies in 2025. Trend: 2023 $514 · 2024 $571 · 2025 $739
Food & beverage: $739
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 6 | $183 |
| Teva Pharmaceuticals USA, Inc. | 3 | $148 |
| Amgen Inc. | 1 | $92 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $88 |
| Otsuka America Pharmaceutical, Inc. | 2 | $37 |
| Lilly USA, LLC | 1 | $32 |
| Ardelyx, Inc. | 1 | $31 |
| Exact Sciences Corporation | 1 | $29 |
| Neurocrine BioSciences, Inc. | 1 | $23 |
| ABBVIE INC. | 1 | $21 |
Products named: Ozempic, AUSTEDO XR, Repatha, Kerendia, REXULTI, MOUNJARO, IBSRELA, Cologuard Collection Kit.
Industry payments across CA — which companies pay providers there.
